Development and Internal Validation of an In Vitro-in Vivo Correlation for a Hydrophilic Metoprolol Tartrate Extended Release Tablet Formulation

被引:0
|
作者
Natalie D. Eddington
Patrick Marroum
Ramana Uppoor
Ajaz Hussain
Larry Augsburger
机构
[1] University of Maryland at Baltimore,Pharmacokinetics Biopharmaceutics Laboratory
[2] University of Maryland at Baltimore,Department of Pharmaceutical Sciences, School of Pharmacy
[3] Food and Drug Administration,undefined
[4] Office of Pharmaceutical Sciences,undefined
来源
Pharmaceutical Research | 1998年 / 15卷
关键词
convolution; metoprolol; validation; dissolution; prediction errors;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose. To develop and validate internally an in vitro-in vivo correlation (IVIVC) for a hydrophilic matrix extended release metoprolol tablet.
引用
收藏
页码:466 / 473
页数:7
相关论文
共 50 条
  • [1] Development and internal validation of an in vitro in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation
    Eddington, ND
    Marroum, P
    Uppoor, R
    Hussain, A
    Augsburger, L
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (03) : 466 - 473
  • [2] Development and internal validation of an in vitro in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation (vol 15, pg 466, 1998)
    Eddington, ND
    Marroum, P
    Uppoor, R
    Hussain, A
    Augsburger, L
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (08) : 1320 - 1320
  • [3] Development of In Vitro-In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
    Mohamed, Mohamed-Eslam F.
    Trueman, Sheryl
    Othman, Ahmed A.
    Han, Jian-Hwa
    Ju, Tzuchi R.
    Marroum, Patrick
    [J]. AAPS JOURNAL, 2019, 21 (06):
  • [4] Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate
    Mahayni, H
    Rekhi, GS
    Uppoor, RS
    Marroum, P
    Hussain, AS
    Augsburger, LL
    Eddington, ND
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (10) : 1354 - 1361
  • [5] DEVELOPMENT OF IN VITRO-IN VIVO CORRELATION FOR ENCAPSULATED METOPROLOL TARTRATE
    Khaled, Abdulhakim A. A.
    Pervaiz, Khalid
    Karim, Sabiha
    Farzana, Kalsoom
    Murtaza, Ghulam
    [J]. ACTA POLONIAE PHARMACEUTICA, 2013, 70 (04): : 743 - 747
  • [6] Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation
    Rajendar K. Mittapalli
    Silpa Nuthalapati
    Alyssa E. Delke DeBord
    Hao Xiong
    [J]. Pharmaceutical Research, 2017, 34 : 1187 - 1192
  • [7] Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation
    Mittapalli, Rajendar K.
    Nuthalapati, Silpa
    DeBord, Alyssa E. Delke
    Xiong, Hao
    [J]. PHARMACEUTICAL RESEARCH, 2017, 34 (06) : 1187 - 1192
  • [8] Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data
    Mittapalli, Rajendar K.
    Marroum, Patrick
    Qiu, Yihong
    Apfelbaum, Kathleen
    Xiong, Hao
    [J]. PHARMACEUTICAL RESEARCH, 2017, 34 (07) : 1527 - 1533
  • [9] Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data
    Rajendar K. Mittapalli
    Patrick Marroum
    Yihong Qiu
    Kathleen Apfelbaum
    Hao Xiong
    [J]. Pharmaceutical Research, 2017, 34 : 1527 - 1533
  • [10] Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
    Mohamed-Eslam F. Mohamed
    Sheryl Trueman
    Ahmed A. Othman
    Jian-Hwa Han
    Tzuchi R. Ju
    Patrick Marroum
    [J]. The AAPS Journal, 21